Trial Profile
Phase II trial of sarsasapogenin [PYM 50028] in patients with Alzheimer's disease
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 17 Oct 2013
Price :
$35
*
At a glance
- Drugs Sarsasapogenin (Primary)
- Indications Alzheimer's disease
- Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
- 21 Oct 2005 New trial record.